Although some Indian states such as Uttar Pradesh allow for the use of Ivermectin off label as a treatment option as well as a prophylaxis for COVID-19, sources recently shared with Indian media that the Indian Council of Medical Research (ICMR)’s National Task Force for COVID-19 and the Joint Monitoring Group recently held a meeting to determine if the drug would be included in the Health Ministry’s Clinical Management Protocol for COVID-19—it will not.
Relatively Safe & Approved Drug
Ivermectin is approved by Indian authorities for indication against parasites, such as scabies and intestinal parasites (as is the case in the United States). The relatively safe and cheap drug has been embraced in many nations as a treatment for COVID-19. Interest started after a Monash University (Australia) lab demonstrated in vitro that Ivermectin zaps the SARS-CoV-2 within 48 hours. After a number of case series efforts in various primarily developing nations occurred, from Bangladesh to Peru and even the United States. TrialSite has been at the forefront reporting on these unfolding hospital protocols, observational studies and even a couple randomized controlled trials. Search Trial...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).